Literature DB >> 7542995

Macroamylasemia associated with ulcerative colitis.

Y Fujimura1, C Nishishita, J Uchida, M Iida.   

Abstract

We describe a very rare case in which macroamylasemia was associated with ulcerative colitis of total colitis type. The patient's serum amylase isozyme pattern by electrophoresis showed a broad abnormal peak toward the side of the positive pole compared with regular salivary and pancreatic fractions. Sephadex G-200 column chromatography showed a sedimentation coefficient of 6.6 S. Amylase activity was bound to IgG. Double diffusion experiments demonstrated that amylase activity could be precipitated in gel by an antibody to the lambda chain. Although inflammatory bowel disease is occasionally associated with hyperamylasemia due to pancreatitis, we emphasize that, when hyperamylasemia is recognized in patients with inflammatory bowel disease, macroamylasemia also should be considered.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7542995     DOI: 10.1007/bf00270584

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  18 in total

1.  Regional enteritis: associated visceral changes.

Authors:  L E CHAPIN; H H SCUDAMORE; A H BAGGENSTOSS; J A BARGEN
Journal:  Gastroenterology       Date:  1956-03       Impact factor: 22.682

2.  Celiac disease and macroamylasemia.

Authors:  L Larvol; J P Chagnon; M Cerf
Journal:  Am J Gastroenterol       Date:  1991-06       Impact factor: 10.864

3.  Amylase transport across ileal epithelium in vitro.

Authors:  H Götze; S S Rothman
Journal:  Biochim Biophys Acta       Date:  1978-09-11

Review 4.  Macroamylasemia: a biochemical or clinical problem?

Authors:  A Van Gossum
Journal:  Dig Dis       Date:  1989       Impact factor: 2.404

5.  Hyperamylasemia in inflammatory bowel disease.

Authors:  S Katz; S Bank; R E Greenberg; S Lendvai; M Lesser; B Napolitano
Journal:  J Clin Gastroenterol       Date:  1988-12       Impact factor: 3.062

6.  Macroamylasemia: a newly recognized cause for elevated serum amylase activity.

Authors:  J E Berk; H Kizu; P Wilding; R L Searcy
Journal:  N Engl J Med       Date:  1967-11-02       Impact factor: 91.245

7.  Macroamylasemia--survey of prevalence in a mixed population.

Authors:  D Barrows; J E Berk; L Fridhandler
Journal:  N Engl J Med       Date:  1972-06-22       Impact factor: 91.245

8.  Macroamylasemia: clinical and laboratory features.

Authors:  J E Berk; H Kizu; S Take; L Fridhandler
Journal:  Am J Gastroenterol       Date:  1970-03       Impact factor: 10.864

9.  Idiopathic pancreatitis associated with inflammatory bowel disease.

Authors:  J A Seyrig; R Jian; R Modigliani; D Golfain; C Florent; B Messing; A Bitoun
Journal:  Dig Dis Sci       Date:  1985-12       Impact factor: 3.199

10.  Serum amylase and macroamylase in patients with systemic lupus erythematosus.

Authors:  P Hasselbacher; A R Myers; F C Passero
Journal:  Br J Rheumatol       Date:  1988-06
View more
  1 in total

Review 1.  Pancreatic Disorders in Patients with Inflammatory Bowel Disease.

Authors:  Marilia L Montenegro; Juan E Corral; Frank J Lukens; Baoan Ji; Paul T Kröner; Francis A Farraye; Yan Bi
Journal:  Dig Dis Sci       Date:  2021-02-24       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.